Zoono Group (ZNO) Fair Value & Analysis
Consumer Defensive · AU · Market cap A$28.4M
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 4 days ago
Fair value updated Jun 26, 2026 — revised from A$0.0400 to A$0.0302 (−24.5%) since Jun 24, 2026. Share price −27.0% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.0294 – A$0.1521 · the A$0.0530 price screens above the A$0.0302 fair value. As of Jun 26, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Zoono Group (ZNO) currently trades at A$0.0530, while our model-based Fair Value estimate is A$0.0302 — implying the stock looks roughly 43.0% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at A$1.0M. Revenue declined 28.6% year over year. It earns a return on equity of -78.4%. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. It offers hand and surface sanitisers, textile applicator, and mould remediation products. Zoono Group Limited was founded in 2007 and is headquartered in Auckland, New Zealand.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Zoono Group reported revenue of A$1.2M in FY2025 versus A$25.2M in FY2021, a compound −53.7%/yr. Reported net income was −A$3.6M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 1,732 MXN | -33% |
| L'Oréal S.A LRLCF | $450.56 | $209.17 | -54% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €77.60 | €36.69 | -53% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,170 | ₹807.38 | -63% |
| Reckitt Benckiser Group RBGLY | $12.32 | $17.37 | +41% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Zoono Group (ZNO) undervalued?
What is the fair value of ZNO?
What is the quality score of ZNO?
What is the revenue of Zoono Group (ZNO)?
What is the net profit margin of ZNO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.